Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Antidotes Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Antidotes Market Status and Forecast (2016-2027)
      • 1.3.2 Global Antidotes Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Antidotes Supply by Company

    • 2.1 Global Antidotes Sales Volume by Company
    • 2.2 Global Antidotes Sales Value by Company
    • 2.3 Global Antidotes Price by Company
    • 2.4 Antidotes Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Antidotes Market Status by Category

    • 3.1 Antidotes Category Introduction
      • 3.1.1 Chemical Antidotes
      • 3.1.2 Physical Antidotes
      • 3.1.3 Pharmacological Antidotes
    • 3.2 Global Antidotes Market by Category
      • 3.2.1 Global Antidotes Sales Volume by Category (2016-2021)
      • 3.2.2 Global Antidotes Sales Value by Category (2016-2021)
      • 3.2.3 Global Antidotes Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Antidotes Market Status by End User/Segment

    • 4.1 Antidotes Segment by End User/Segment
      • 4.1.1 Pesticide Poisoning
      • 4.1.2 Heavy Metal Poisoning
      • 4.1.3 Animal Bites Poisoning
      • 4.1.4 Cyanide Poisoning
      • 4.1.5 Others
    • 4.2 Global Antidotes Market by End User/Segment
      • 4.2.1 Global Antidotes Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Antidotes Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Antidotes Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Antidotes Market Status by Region

    • 5.1 Global Antidotes Market by Region
      • 5.1.1 Global Antidotes Sales Volume by Region
      • 5.1.2 Global Antidotes Sales Value by Region
    • 5.2 North America Antidotes Market Status
    • 5.3 Europe Antidotes Market Status
    • 5.4 Asia Pacific Antidotes Market Status
    • 5.5 Central & South America Antidotes Market Status
    • 5.6 Middle East & Africa Antidotes Market Status

    6 North America Antidotes Market Status

    • 6.1 North America Antidotes Market by Country
      • 6.1.1 North America Antidotes Sales Volume by Country (2016-2021)
      • 6.1.2 North America Antidotes Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Antidotes Market Status

    • 7.1 Europe Antidotes Market by Country
      • 7.1.1 Europe Antidotes Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Antidotes Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Antidotes Market Status

    • 8.1 Asia Pacific Antidotes Market by Country
      • 8.1.1 Asia Pacific Antidotes Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Antidotes Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Antidotes Market Status

    • 9.1 Central & South America Antidotes Market by Country
      • 9.1.1 Central & South America Antidotes Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Antidotes Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Antidotes Market Status

    • 10.1 Middle East & Africa Antidotes Market by Country
      • 10.1.1 Middle East & Africa Antidotes Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Antidotes Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Antidotes Distributors
    • 11.3 Antidotes Buyers

    12 Global Antidotes Market Forecast by Category and by End User/Segment

    • 12.1 Global Antidotes Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Antidotes Forecast by Category
      • 12.2.1 Global Antidotes Sales Volume Forecast by Category
      • 12.2.2 Global Antidotes Sales Value Forecast by Category
      • 12.2.3 Global Antidotes Price Forecast by Category
    • 12.3 Global Antidotes Forecast by End User/Segment
      • 12.3.1 Global Antidotes Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Antidotes Sales Value Forecast by End User/Segment
      • 12.3.3 Global Antidotes Price Forecast by End User/Segment

    13 Global Antidotes Market Forecast by Region/Country

    • 13.1 Global Antidotes Market Forecast by Region (2022-2027)
      • 13.1.1 Global Antidotes Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Antidotes Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Roche
      • 14.1.1 Company Information
      • 14.1.2 Antidotes Product Introduction
      • 14.1.3 Roche Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Antidotes Product Introduction
      • 14.2.3 Pfizer Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Teva
      • 14.3.1 Company Information
      • 14.3.2 Antidotes Product Introduction
      • 14.3.3 Teva Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Bayer
      • 14.4.1 Company Information
      • 14.4.2 Antidotes Product Introduction
      • 14.4.3 Bayer Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Boehringer Ingelheim
      • 14.5.1 Company Information
      • 14.5.2 Antidotes Product Introduction
      • 14.5.3 Boehringer Ingelheim Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Baxter
      • 14.6.1 Company Information
      • 14.6.2 Antidotes Product Introduction
      • 14.6.3 Baxter Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Novartis
      • 14.7.1 Company Information
      • 14.7.2 Antidotes Product Introduction
      • 14.7.3 Novartis Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Eli Lilly
      • 14.8.1 Company Information
      • 14.8.2 Antidotes Product Introduction
      • 14.8.3 Eli Lilly Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Johnson & Johnson
      • 14.9.1 Company Information
      • 14.9.2 Antidotes Product Introduction
      • 14.9.3 Johnson & Johnson Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Furen Pharmaceutical
      • 14.10.1 Company Information
      • 14.10.2 Antidotes Product Introduction
      • 14.10.3 Furen Pharmaceutical Antidotes Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Fresenius Kabi
    • 14.12 Mylan

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Antidotes market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Antidotes market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Chemical Antidotes
    Physical Antidotes
    Pharmacological Antidotes

    Segmented by End User/Segment
    Pesticide Poisoning
    Heavy Metal Poisoning
    Animal Bites Poisoning
    Cyanide Poisoning
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Roche
    Pfizer
    Teva
    Bayer
    Boehringer Ingelheim
    Baxter
    Novartis
    Eli Lilly
    Johnson & Johnson
    Furen Pharmaceutical
    Fresenius Kabi
    Mylan
    Buy now